A quantitative autoradiographic assay for a novel L-[3H]glutamate binding site in rodent brain has been developed. Binding to this site was distinguished by its high affinity for quisqualate (QA), ibotenate, glutamate and trans-l-amino-cyclopentyl-l,3-dicarboxylic acid 
. AiQsGB was greatest at 4°C and was reduced at 23°C and 37°C. The anion channel blocker, SITS (100/~M), displaced only 30% of binding and cystine (100/iM), which potently inhibits chloride dependent glutamate sequestration, blocked less than 25% of binding [8, 10] . Quisqualate was the most potent displacer of AiQsGB, followed by glutamate, ibotenate and trans-ACPD. The latter two drugs had no effect on [3H]AMPA binding. L-APB, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 6,7-dinitroquinoxaline-2,3-dione (DNQX), kainate, L-aspartate, glutamyl-diethyl ester (GDEE), ~-D-glutamylglycine (~-DGG) and kynurenate were all ineffective displacers (ICs0s > 100/iM) of binding. The effective displacers of AiQsGB, quisqualate, glutamate, trans-ACPD and ibotenate, have all been shown to increase inositol phospholipid metabolism in tissue slices, neuronal cultures and/or synaptoneurosomes [6, 7,11-13, [16] [17] [18] [19] . The present ICs0 values for these compounds are lower than previously reported ECs0 values for stimulation of inositol phospholipid metabolism. This difference may be due to a number of factors, including the temperature of the assay and the removal of inactivation systems for glutamate. In other neurotransmitter agonist binding studies, binding constants are frequently one to two orders of magnitude lower than the ECs0 for stimulation of a physiological response, e.g. acetylcholine, GABA and dopamine. Thus, the pharmacology of this binding site was consistent with that of the metabotropic receptor and distinct from that of the AMPA-sensitive ionotropic receptor [2, 10, 14, 17, 18] .
The regional distribution of AiQsGB is different from that of other EAA receptors (°P < 0.0006), whereas AiQsGB levels were not significantly different in the granule cell layer. Abbreviations: InfColl, inferior colliculus; LatSep, lateral septum; FrParCtx, fronto-parietal cortex; CingCtx, cingulate cortex; EntCtx, entorhinal cortex; SMDG, stratum moleculare of dentate gyrus; SRoCA3, stratum radiatum of CA3; SP-CA3, stratum pyramidale of CA3; SO-CA3, stratum oriens of CA3; Thal, thalamus; CerGrn, cerebellar granule cell layer; CerMol, cerebellar molecular layer. Numbers after cortex labels refer to cortical layers.
[2, 10, 14] (Fig. 1A) . Binding was highest in lateral septum and cerebellar molecular layer. Binding was also dense in striatum, cingulate and entorhinal cortices and lower in hippocampus. Thalamus, brainstem and frontal-parietal cortex had low binding densities.
In cerebellar Purkinje neurons, quisqualate produces longer lasting responses than other EAA's and these responses persist after diffusion of the quisqualate, suggesting the activation of a second messenger system [6] . In rat cerebellar slices, quisqualate and glutamate but not AMPA stimulate inositol phosphate turnover, whereas in cerebellar slices from mutant mice lacking Purkinje cells, glutamate stimulation of phosphoinositide turnover is abolished [1] . We examined the neuronal localization of AiQsGB in mouse cerebellum (Fig. 1B) . In nervous mutant mice (which lack Purkinje cells), AiQsGB was markedly reduced in the cerebellar molecular layer, the area in which Purkinje cell dendrites are found, compared to binding in heterozygous littermate controls (Fig. 1B). [3H]AMPA binding and total quisqualate-sensitive [3H]glutamate binding also were very reduced in nervous mutants [9, 15] . Thus, both ionotropic and metabotropic quisqualate receptors appear to be concentrated on Purkinje cells. The ionotropic receptor is the likely mediator of fast synaptic transmission at the parallel fiber Purkinje cell synapses whereas the metabotropic receptor probably plays a role in the generation of the longer lasting quisqualate responses and long-term depression observed in cerebellum [6, 7] . The evidence from mutant mouse cerebella strongly suggests that AiQsGB is localized on postsynaptic neuronal elements rather than on presynaptic or glial sites.
The present study suggests that AiQsGB represents L-[3H]glutamate binding to the metabotropic EAA receptor. AiQsGB is distinct from [3H]AMPA binding, is differentially distributed throughout the rat brain, and is likely localized to postsynaptic elements. The development of a binding assay for this receptor site should allow its evaluation in human hypoxic-ischemic and neurodegenerative brain pathology and facilitate the identification of more selective and potent agonists and antagonists.
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